5 Healthcare Dividend Stocks with Over 3% Yield

3. GlaxoSmithKline plc (NYSE:GSK)

Dividend Yield as of December 13: 4.98%

Number of Hedge Fund Holders: 31

GlaxoSmithKline plc (NYSE:GSK) is a UK-based multinational company specializing in prescription medicines, vaccines, and consumer healthcare products. GlaxoSmithKline plc (NYSE:GSK) reported on October 27 its Q3 results. EPS in the quarter equaled $1.01, beating estimates by $0.19. The revenue increased 11.10% year-over-year to $12.47 billion, exceeding estimates by $529.13 million. 

Berenberg analyst Luisa Hector on November 24 raised the price target on GlaxoSmithKline plc (NYSE:GSK) to £1,630 from £1,540 and kept a Buy rating on the shares.

Arrowstreet Capital is one of the leading GlaxoSmithKline plc (NYSE:GSK) stakeholders, increasing its stake in the company by 108% in the third quarter, holding 3.72 million shares worth $142.3 million. Overall, 31 hedge funds monitored by Insider Monkey reported owning stakes in GlaxoSmithKline plc (NYSE:GSK) in Q3 2021, up from 28 funds in the preceding quarter. 

With a forward yield of 4.98%, GlaxoSmithKline plc (NYSE:GSK) is one of the best healthcare dividend stocks to invest in.